Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3

Blood

Volumn 87, Issue 1, 1996, Pages 404-411

  Buysmann, Saskia ^b   Bemelman, Frederike J ^b   Schellekens, Peter Th A ^b   Van Kooyk, Yvette ^b   Figdor, Carl G ^b   Ten Berge, Ineke J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; CYCLOSPORIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTOPENIA; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030032019     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.404.bloodjournal871404     Document Type: Article

References (34)

1. Norman DJ: Rationale for OKT3 monoclonal antibody treatment in transplant patients. Transplant Proc 25.1, 1993 (suppl 1)
2. Abramowicz D, Goldman M: OKT3 for induction of immunosuppression in renal transplantation. Clin Transpl 7:382, 1993
3. DeMattos AM, Norman DJ: OKT3 for treatment of rejection in renal transplantation. Clin Transpl 7:374, 1993
4. Chatenoud L, Baudrihaye MF, Kreis H, Goldstein GG, Schindler J, Bach JF: Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur J Immunol 12:979, 1982
5. Kreis H, Legendre C, Chatenoud L: OKT3 in organ transplantation. Transplant Rev 5:181, 1991
6. Gaston RS, Deierhoi MH, Patterson T, Prasthofer E, Julian BA, Barber WH, Laskow DA, Diethelm AG, Curtis JJ: OKT3 first dose reaction: Association with T cell subsets and cytokine release. Kidney Int 39:141, 1991
7. Roitt IM: OKT3: Immunology, production, purification, and pharmacokinetics. Clin Transpl 7:367, 1993
8. Parlevliet KJ, Jonker M, ten Berge RJM, van Lier RAW, Wilmink JM, Strengers PFW, Aarden LA, Schellekens PThA. Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees. Transplantation 50:889, 1990
9. Parlevliet KJ, ten Berge RJM, Yong SL, Surachno S, Wilmink JM, Schellekens PThA: In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. J Clin Invest 93:2519, 1994
10. Shimizu Y, Newman W, Tanaka Y, Shaw S: Lymphocyte interactions with endothelial cells. Immunol Today 13:106, 1992
11. Dustin ML, Springer TA: T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341:619, 1989
12. Figdor CG, van Kooyk Y, Keizer GD: On the mode of action of LFA-1. Immunol Today 11:277, 1990
13. 2+ dependent epitope stimulates lymphocyte adhesion. J Cell Biol 112:345, 1991
14. Kolk AHJ, Ho MLY, Klatser PR, Eggelte TA, Kuijper S, de Jonge S, van Leeuwen J: Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae. Clin Exp Immunol 58:511, 1984
15. Goldstein G, Norman DJ, Henell KR, Smith IL: Pharmacokinetic study of orthoclone OKT3 serum levels during treatment of acute renal allograft rejection. Transplantation 46:587, 1988
16. Fontijn R, Hop C, Brinkman HJ, van Mounk JA, Slater R, Westerveld A, Pannekoek H: Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Exp Cell Res 216:199, 1995
17. Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA: Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2. and LFA-3. Proc Natl Acad Sci USA 79:7489, 1982
18. Keizer GD, Visser W, Vliem M, Figdor CG: A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J Immunol 140:1393, 1988
19. Keizer GD, Borst J, Figdor CG, Spits H, Miedema F, Terhorst C, de Vries JE: Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150.95. Eur J Immunol 15:1142, 1985
20. MEL14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. J Immunol 144:3130, 1990
21. Tedder TF, Penta AC, Levine HB, Freedman AS: Expression of the human leukocyte adhesion molecule, LAM1; Identity with the TQ1 and Leu-8 differentiation antigens. J Immunol 144:532, 1990
22. Muto S, Vetvicka V, Ross GD: CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol 13:175, 1993
23. Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, de Pauw L, Wybran J, Kinnaeri P, Dupont E, Toussaint C: Release of tumor necrosis factor, Interleukin-2 and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47:606, 1989
24. Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchtmont P, Bach JF: In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation 49:697, 1990
25. Salvo G, Samoggia P, Masciulli R, Boccoli G, Allavena P, Mariani G, Bullo A, Montesoro E, Bulgarini D, Carlini P, Ruggeri EM, Arena MG, Camagna A, Testa U, Calabresi F, Peschle C: Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: Role of cell adhesion to endothelium. Eur J Cancer 28A:818, 1992
26. Aronson FR, Libby P, Brandon EP, Janicka MW, Mier JW: II-2 rapidly induces natural killer cell adhesion to human endothelial cells: A potential mechanism for endothelial injury. J Immunol 141:158, 1988
27. Pankonin G, Reipert B, Ager A: Interactions between II-2 activated lymphocytes and vascular endothelium: Binding to and migration across specialized and nonspecialized endothelia. Immunology 77:51, 1992
28. ten Berge RJM, Sauerwein HP, Yong SL, Schellekens PThA: Administration of prednisolone in vivo affects the ratio of OKT4/ OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. Clin Immunol Immunopathol 30:91, 1984
29. Buysmann S, van Diepen FNJ, Yong SL, Surachno S, Schellekens PThA, ten Berge RJM: Mechanism of lymphocytopenia following administration of corticosteroids. Transplant Proc 27:871, 1995
30. Dustin ML, Springer TA: Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 107-321, 1988
31. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a side distinct from the VLA-4/tibionectin binding site Cell 60:577, 1990
32. Carlos TM, Schwartz BR, Kovach NL, Yee E, Rosso M, Osborn L, Chi-Rosso G, Newman B, Lobb R, Harlan JM: Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 76:965, 1990
33. Shimizu Y, Newman W, Venkat Gopal T, Horgan KJ, Graber N, Dawson Beall L, van Seventer GA, Shaw S: Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113:1203, 1991
34. Bergese SD, Pelletier RP, Ohye RG, Vallera DA, Orosz CG: Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression. Transplantation 57:711, 1994